Drug Profile
Research programme: CNS therapeutics - Amorsa Therapeutics
Alternative Names: Amorsa K-ER; K-ER12; KA-ER12; KA-FALatest Information Update: 10 Oct 2023
Price :
$50
*
At a glance
- Originator Amorsa Therapeutics
- Class Analgesics; Antidepressants; Small molecules
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Depressive disorders; Pain
Most Recent Events
- 01 Oct 2023 Janssen Pharmaceuticals is now called Johnson & Johnson Innovative Medicine (Janssen Pharmaceuticals website, October 2023)
- 28 Dec 2020 No recent reports of development identified for research development in Depressive disorders in USA
- 28 Dec 2020 No recent reports of development identified for research development in Pain in USA